Baxter International (BAX) plans to announce its 2Q17 earnings results on July 26, 2017. For the last few quarters, the company has exceeded analysts’ earnings estimates. A company’s stock price is usually impacted by the deviation in …
In the last ninety days, insiders have sold 62,013 shares of company stock valued …
If you check you will find that BAX stock has a topline or revenue of $2.61B for 2017-Q2 as per this Baxter International revenue chart. Investors look for stocks with a growing top line. Bottom line: The word bottom line comes because it is …
Baxter International Inc. (NYSE: BAX) stock was boosted nearly 10% to a 52-week high of $75.68 intraday Thursday after the healthcare giant announced it's splitting into two separate companies. The two new entities will include one …
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic …
Baxter International Inc. (NYSE:BAX)’s stock on Monday traded at beginning with a price of $62.10 and when day-trade …
(NYSE:BAX) opened at 62.67 on Friday. The stock last traded at $63.04 a tad higher than $60.23, the 50 day moving average and a tad above the 200 day moving average of $53.80. The P/E ratio is 18.66 and the market cap is 34.27B. …
Baxter International Inc (NYSE:BAX)‘s stock had its “hold” rating reiterated by stock analysts at BMO Capital Markets in a research note issued to investors on Thursday, April 27th. They presently have a $55.00 price objective on the medical ...
Goldman Sachs Group Inc reissued their conviction-buy rating on shares of Baxter International Inc (NYSE:BAX) in a research note issued to investors on Tuesday, May 16th. The firm currently has a $71.00 target price on the medical …
Breeze2mon
Baxter (BAX) stock fell Monday on worries related to a Department of Justice investigation into potential price fixing of intravenous fluids — allegations an analyst deemed "extraordinary." On the stock market today, Baxter stock fell 0.8% …